Your browser doesn't support javascript.
loading
A Large, Refractory Nosocomial Outbreak of Klebsiella pneumoniae Carbapenemase-Producing Escherichia coli Demonstrates Carbapenemase Gene Outbreaks Involving Sink Sites Require Novel Approaches to Infection Control.
Decraene, V; Phan, H T T; George, R; Wyllie, D H; Akinremi, O; Aiken, Z; Cleary, P; Dodgson, A; Pankhurst, L; Crook, D W; Lenney, C; Walker, A S; Woodford, N; Sebra, R; Fath-Ordoubadi, F; Mathers, A J; Seale, A C; Guiver, M; McEwan, A; Watts, V; Welfare, W; Stoesser, N; Cawthorne, J.
Afiliação
  • Decraene V; Field Service North West, Public Health England, Liverpool, United Kingdom.
  • Phan HTT; Nuffield Department of Clinical Medicine, Oxford University, John Radcliffe Hospital, Oxford, United Kingdom.
  • George R; National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Oxford University, John Radcliffe Hospital, Oxford, United Kingdom.
  • Wyllie DH; Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.
  • Akinremi O; Nuffield Department of Clinical Medicine, Oxford University, John Radcliffe Hospital, Oxford, United Kingdom.
  • Aiken Z; National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Oxford University, John Radcliffe Hospital, Oxford, United Kingdom.
  • Cleary P; National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Oxford University, John Radcliffe Hospital, Oxford, United Kingdom.
  • Dodgson A; Antimicrobial Resistance and Healthcare-Associated Infections Reference Unit, National Infection Service, Public Health England, London, United Kingdom.
  • Pankhurst L; Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.
  • Crook DW; Field Service North West, Public Health England, Liverpool, United Kingdom.
  • Lenney C; Nuffield Department of Clinical Medicine, Oxford University, John Radcliffe Hospital, Oxford, United Kingdom.
  • Walker AS; Public Health Laboratory Manchester, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
  • Woodford N; Nuffield Department of Clinical Medicine, Oxford University, John Radcliffe Hospital, Oxford, United Kingdom.
  • Sebra R; National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Oxford University, John Radcliffe Hospital, Oxford, United Kingdom.
  • Fath-Ordoubadi F; Nuffield Department of Clinical Medicine, Oxford University, John Radcliffe Hospital, Oxford, United Kingdom.
  • Mathers AJ; National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Oxford University, John Radcliffe Hospital, Oxford, United Kingdom.
  • Seale AC; Antimicrobial Resistance and Healthcare-Associated Infections Reference Unit, National Infection Service, Public Health England, London, United Kingdom.
  • Guiver M; Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.
  • McEwan A; Nuffield Department of Clinical Medicine, Oxford University, John Radcliffe Hospital, Oxford, United Kingdom.
  • Watts V; National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Oxford University, John Radcliffe Hospital, Oxford, United Kingdom.
  • Welfare W; National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Oxford University, John Radcliffe Hospital, Oxford, United Kingdom.
  • Stoesser N; Antimicrobial Resistance and Healthcare-Associated Infections Reference Unit, National Infection Service, Public Health England, London, United Kingdom.
  • Cawthorne J; Icahn Institute, Department of Genetics and Genomic Sciences, Icahn School of Medicine Mount Sinai, New York, New York, USA.
Article em En | MEDLINE | ID: mdl-30249685
ABSTRACT
Carbapenem-resistant Enterobacteriaceae (CRE) represent a health threat, but effective control interventions remain unclear. Hospital wastewater sites are increasingly being highlighted as important potential reservoirs. We investigated a large Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli outbreak and wider CRE incidence trends in the Central Manchester University Hospital NHS Foundation Trust (CMFT) (United Kingdom) over 8 years, to determine the impact of infection prevention and control measures. Bacteriology and patient administration data (2009 to 2017) were linked, and a subset of CMFT or regional hospital KPC-producing E. coli isolates (n = 268) were sequenced. Control interventions followed international guidelines and included cohorting, rectal screening (n = 184,539 screens), environmental sampling, enhanced cleaning, and ward closure and plumbing replacement. Segmented regression of time trends for CRE detections was used to evaluate the impact of interventions on CRE incidence. Genomic analysis (n = 268 isolates) identified the spread of a KPC-producing E. coli outbreak clone (strain A, sequence type 216 [ST216]; n = 125) among patients and in the environment, particularly on 2 cardiac wards (wards 3 and 4), despite control measures. ST216 strain A had caused an antecedent outbreak and shared its KPC plasmids with other E. coli lineages and Enterobacteriaceae species. CRE acquisition incidence declined after closure of wards 3 and 4 and plumbing replacement, suggesting an environmental contribution. However, ward 3/ward 4 wastewater sites were rapidly recolonized with CRE and patient CRE acquisitions recurred, albeit at lower rates. Patient relocation and plumbing replacement were associated with control of a clonal KPC-producing E. coli outbreak; however, environmental contamination with CRE and patient CRE acquisitions recurred rapidly following this intervention. The large numbers of cases and the persistence of blaKPC in E. coli, including pathogenic lineages, are of concern.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Beta-Lactamases / Infecção Hospitalar / Surtos de Doenças / Escherichia coli / Infecções por Escherichia coli / Klebsiella pneumoniae Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Beta-Lactamases / Infecção Hospitalar / Surtos de Doenças / Escherichia coli / Infecções por Escherichia coli / Klebsiella pneumoniae Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article